Poor clinical outcome in metastatic melanoma is associated with a microRNA-modulated immunosuppressive tumor microenvironment.

Natasha A N JorgeJéssica G V CruzMarco Antônio M PrettiMartín H BonaminoPatricia A PossikMariana Boroni

Published in: Journal of translational medicine (2020)

Our results underscore the impact of tumor-microenvironment interactions on disease outcomes and reveal potential non-invasive biomarkers of prognosis and treatment response.

Keyphrases

genome wide
single cell
human health
type diabetes
adipose tissue